Example: Heart Attack

Search clinical trials for: Delavirdine

Total 27 results

NCT00823966

Completed

Safety And Efficacy Of Rescriptor In Patients For Human Immunodeficiency Virus (HIV) Patients

Conditions: HIV-1 Infection
NCT00002210

Completed

A Study of Delavirdine Mesylate in Combination With Other Anti-HIV Drugs in HIV-Infected Children and Babies

Conditions: HIV Infections
NCT00002123

Completed

A Double-Blind, Randomized, Comparative Study of Delavirdine Mesylate (U-90152S) in Combination With Didanosine (ddI) Versus ddI Alone in HIV-1 Infected Individuals With CD4 Counts of <= 300/mm3

Conditions: HIV Infections
NCT00002312

Completed

The Safety and Effectiveness of U-90152 in HIV-1 Infected Patients Who Take Zidovudine

Conditions: HIV Infections
NCT00002236

Completed

A Study to Find the Best Dosing Schedule for Delavirdine, Zidovudine, and Indinavir in HIV-Positive Patients

Conditions: HIV Infections
NCT00000810

Completed

Randomized, Phase I/II, Dose-Ranging, Open-Label Trial of the Anti-HIV Activity of Delavirdine Mesylate (DLV; U-90,152S)

Conditions: HIV Infections
NCT00000803

Completed

A Phase II Double-Blind Study of Delavirdine Mesylate ( U-90152 ) in Combination With Zidovudine ( AZT ) and/or Didanosine ( ddI ) Versus AZT and ddI Combination Therapy

Conditions: HIV Infections
NCT00002124

Completed

A Double-Blind, Randomized, Dose Response Study of Three Doses of Delavirdine Mesylate (U-90152S) in Combination With Zidovudine (ZDV) Versus ZDV Alone in HIV-1 Infected Individuals With CD4 Counts of 200-500mm3

Conditions: HIV Infections
NCT00002401

Completed

A Study of Delavirdine Used Together With Other Anti-HIV Drugs in HIV-Infected Patients

Conditions: HIV Infections
NCT02249130

Completed

Tipranavir Dose-response Study Using a Prototype Self-emulsifying Drug Delivery System (SEDDS) Formulation in Treatment-naive HIV-1 Infected Patients Report on the Post-study Option, a Treatment of Triple Therapy With Delavirdine, ZDV and 3TC Without Tipranavir

Conditions: HIV Infections
NCT00001094

Withdrawn

A Comparison of Nelfinavir Plus Saquinavir Plus Delavirdine or 3TC/ZDV Versus Nelfinavir Plus 3TC/ZDV in HIV-Infected Patients

Conditions: HIV Infections
NCT00000882

Completed

Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced Subjects

Conditions: HIV Infections
NCT00002420

Terminated

The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors

Conditions: HIV Infections
NCT00002211

Completed

Safety and Effectiveness of Giving Combinations of Three or Four Anti-HIV Drugs to HIV-Infected Patients

Conditions: HIV Infections
NCT00002400

Completed

A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients

Conditions: HIV Infections
NCT00006326

Terminated

Safety and Effectiveness of 3 Anti-HIV Treatments in Patients Who Have Failed Previous Treatments Containing Nelfinavir

Conditions: HIV Infections
NCT00000892

Completed

A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir

Conditions: HIV Infections
NCT00624195

Completed

Clinical Trial of CNS-targeted HAART (CIT2)

Conditions: HIV Infections
NCT00002178

Completed

A Phase IIIB Open-Label, Comparative Study to Evaluate Saquinavir Soft Gel Capsule (SGC) Treatment in Combination With Other Antiretrovirals in HIV-1 Infected Antiretroviral-Naive Patients

Conditions: HIV Infections
NCT01137981

Recruiting

Antiretroviral Pregnancy Registry (APR)-Risk of Birth Defects

Conditions: Infection, Human Immunodeficiency Virus; HIV Infections
NCT00925756

Completed

CCR5 Inhibitor Treatment Intensification on CD4+ T-cell Recovery

Conditions: HIV Infections
NCT00000891

Completed

Immunologic and Virologic Consequences of Long-Term Highly Active Antiretroviral Therapy (HAART) in Subjects With Moderately Advanced HIV-1 Disease: A Follow-Up Study to ACTG 315

Conditions: HIV Infections
NCT00002378

Completed

A Comparison of Three Anti-HIV Drug Combinations Containing Saquinavir Soft Gelatin Capsules Used in HIV-1 Infected Patients

Conditions: HIV Infections
NCT01814722

Terminated

Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)

Conditions: Human Immunodeficiency Virus
NCT02016924

Recruiting

Study Evaluating Pharmacokinetics (PK), Safety, and Efficacy of Cobicistat-boosted Atazanavir (ATV/co) or Cobicistat-boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in HIV-1 Infected, Virologically Suppressed Pediatric Participants

Conditions: Acquired Immune Deficiency Syndrome (AIDS); HIV Infections